2 13G filings
Ownership stake disclosure by Deep Track Capital, LP (amended)
Show all 2
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Deep Track Capital, LP, filed by
ENTA
ENANTA PHARMACEUTICALS INC SEC filings
Every EDGAR filing for ENANTA PHARMACEUTICALS INC (ENTA), newest first, with AI summaries and stories.
- Ticker
- ENTA
- CIK
- 1177648
- Latest filing
- Aug 14
Next: earnings expected ~Nov 23 · 10-K expected ~Nov 25 (deadline Dec 29)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINESCHEDULE 13G/AENANTA PHARMACEUTICALS INCENTALIVE NOTABLE10-QENANTA PHARMACEUTICALS INCENTALIVE ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINE4ENANTA PHARMACEUTICALS INCENTALIVE Scott T. Rottinghaus, insider filing for ENTA
Scott T. Rottinghaus, reporting
ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINE424B5ENANTA PHARMACEUTICALS INCENTALIVE ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINES-8ENANTA PHARMACEUTICALS INCENTALIVE NOTABLE10-QENANTA PHARMACEUTICALS INCENTALIVE ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINESCHEDULE 13G/AENANTA PHARMACEUTICALS INCENTALIVE Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINE4ENANTA PHARMACEUTICALS INCENTALIVE 6 insider filings
Terry Vance, insider filing for ENTA
Show all 6
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
Terry Vance, reporting
ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINEEFFECTENANTA PHARMACEUTICALS INCENTALIVE ROUTINE4ENANTA PHARMACEUTICALS INCENTALIVE 6 insider filings
Matthew Paul Kowalsky, insider filing for ENTA
Show all 6
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
Matthew Paul Kowalsky, reporting
ROUTINESCHEDULE 13G/AENANTA PHARMACEUTICALS INCENTALIVE Ownership stake disclosure by Deep Track Capital, LP (amended)
Deep Track Capital, LP, filed by
ROUTINES-3ENANTA PHARMACEUTICALS INCENTALIVE NOTABLE10-QENANTA PHARMACEUTICALS INCENTALIVE ROUTINE8-KENANTA PHARMACEUTICALS INCENTALIVE ROUTINESCHEDULE 13G/AENANTA PHARMACEUTICALS INCENTALIVE Ownership stake disclosure by Farallon Capital Partners, L.P. (amended)
Farallon Capital Partners, L.P., filed by
ROUTINEARSENANTA PHARMACEUTICALS INCENTALIVE ROUTINEDEFA14AENANTA PHARMACEUTICALS INCENTALIVE ROUTINEDEF 14AENANTA PHARMACEUTICALS INCENTALIVE ROUTINESCHEDULE 13G/AENANTA PHARMACEUTICALS INCENTALIVE Ownership stake disclosure by INTEGRATED CORE STRATEGIES (US) LLC (amended)
INTEGRATED CORE STRATEGIES (US) LLC, filed by
ROUTINE4ENANTA PHARMACEUTICALS INCENTALIVE 7 insider filings
Kathleen S. Capps, insider filing for ENTA
Show all 7
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
Kathleen S. Capps, reporting
ROUTINE144ENANTA PHARMACEUTICALS INCENTALIVE Jay R. Luly, planned sale of ENTA shares
Jay R. Luly, reporting
ROUTINE4ENANTA PHARMACEUTICALS INCENTALIVE 5 insider filings
Kathleen S. Capps, insider filing for ENTA
Show all 5
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
- 4Insider filing for ENTA
Kathleen S. Capps, reporting